Royal Bank of Canada’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2
Closed 7395
2024
Q2
$0 Buy
2
+1
+100% +$109 ﹤0.01% 7499
2024
Q1
$0 Hold
1
﹤0.01% 7549
2023
Q4
$0 Buy
+1
New +$133 ﹤0.01% 7546
2021
Q2
Sell
-3
Closed -$4K 7669
2021
Q1
$4K Buy
+3
New +$5.29K ﹤0.01% 7112
2020
Q4
Sell
-3
Closed -$4K 7267
2020
Q3
$4K Sell
3
-1
-25% -$1.61K ﹤0.01% 6188
2020
Q2
$5K Buy
4
+2
+100% +$3.19K ﹤0.01% 6051
2020
Q1
$3K Buy
+2
New +$9.58K ﹤0.01% 6212
2019
Q4
Hold
0
6575
2019
Q3
Hold
0
-$1K 7073
2019
Q2
Hold
0
6740

Other funds holding SONM

Royal Bank of Canada's SONM Position: Q3 2024 in Review

Royal Bank of Canada sold out of DNA X Inc (SONM) in Q3 2024, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in SONM in Q1 2020 and held it in 7 quarters. The position peaked at $5K in Q2 2020. 8 funds tracked by Wall St. Rank hold SONM as of Q3 2024.

  • Royal Bank of Canada reported no remaining DNA X Inc position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2 DNA X Inc shares in Q3 2024.
  • Royal Bank of Canada first reported a position in DNA X Inc in Q1 2020 and held it in 7 quarters.
  • Royal Bank of Canada's DNA X Inc position peaked at $5K in Q2 2020.
  • 8 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.